Dr Reddy's to employ cost cutting measures

Reddy's Laboratories (DRL), leading drug maker of the country, would employ various cost cutting measures in order to mitigate the impact of global slowdown on its business.

The firm has trimmed its operations in different countries and announced its exit from its global generics business, having less than 1 per cent contribution in its total revenue.